Ugandan Drug Maker Included in Plan to Produce Promising Monthly HIV Prevention Pill
A new HIV prevention pill that only needs to be taken once a month is showing promising results in late-stage clinical trials, raising hopes of expanding options to prevent new HIV infections. The experimental drug, called alimatravir (MK-8527), is being developed by pharmaceutical company Merck Sharp & Dohme (MSD). Unlike the daily HIV prevention pills…

